SUBSCRIBE
SUBSCRIBE

Valeant Pharmaceuticals International

NEWS
Valeant Pharmaceuticals International was acquired by Bausch & Lomb in 2013.
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Valeant Ups Bid for Dendreon Assets to $400 Million After Competing Offers Come In
February 5, 2015
 · 
2 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Deals
Deal-Hungry Valeant Eyes Salix Pharmaceuticals, Ltd. as Its Latest Takeover Target
February 4, 2015
 · 
2 min read
Biotech Bay
After Losing Allergan, Is Valeant Dumpster Diving?
February 2, 2015
 · 
1 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Dendreon Corporation Gets $296 Million Cash Bid From Deal-Hungry Valeant for Provenge Assets as Bankruptcy Auction Looms
January 30, 2015
 · 
2 min read
BioCapital
Valeant Enters Super Bowl Frenzy With 30 Second $4.5 Million Toe Fungus Ad
January 29, 2015
 · 
1 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Deals
Valeant CEO Fesses Up to What Went Wrong in Pursuit of Allergan
January 22, 2015
 · 
4 min read
J.P. Morgan: Bluebird Bio Trading Near Historic Highs
Biotech Beach
J.P. Morgan: Valeant Investors Should Expect “Small and Medium Sized” Deals in 2015, Says CFO
January 13, 2015
 · 
1 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Deals
Valeant Possibly Eyeing Dental Device Makers Such as Align Technology, Inc. and DENTSPLY International Inc. in 2015: Analysts
December 31, 2014
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Valeant To Drop Deal-Making To Cut Debt, Boost Stock
December 10, 2014
 · 
3 min read
Load More
IN THE PRESS
Bausch Health Announces Closing Of Incremental Amendment To Its Existing Credit Agreement And Redemption Of Its 7.500% Senior Notes Due 2021
November 27, 2018
 · 
3 min read
Policy
Perrigo Confirms Patent Challenge for Generic Version of Jublia® Topical Solution 10%
October 1, 2018
 · 
5 min read
Business
Ekso Bionics Appoints Jack Glenn as Chief Financial Officer
August 13, 2018
 · 
4 min read
Drug Development
Strategic appointment expands Atlantic Healthcare executive team
August 8, 2018
 · 
7 min read
Policy
Virtus Thwarts Efforts of Bausch Health (formerly known as Valeant) to Push Lower Priced Competing Drugs off the Market
August 1, 2018
 · 
1 min read
Business
Bausch Health Companies Inc. Completes Name Change
July 13, 2018
 · 
3 min read
FDA
Bausch + Lomb Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38%
July 9, 2018
 · 
3 min read
FDA
FDA Issues Complete Response Letter For DUOBRII™ (Halobetasol Propionate and Tazarotene) Lotion
June 18, 2018
 · 
3 min read
Bausch + Lomb Launches Soothe® Xtra Protection Preservative Free Lubricant Eye Drops
June 14, 2018
 · 
4 min read
Bausch + Lomb Introduces Ocuvite® Blue Light Eye Vitamins
June 12, 2018
 · 
4 min read
Load More